In light of these findings, collectively, our results lead us to propose a mechanistic model in which BRCA1 can promote FOXA1 transcriptional expression and thereby, breast cancer luminal subtype development through targeting EZH2 (Supplementary Figure S12). This evidence concerns the gene FOXA1 and breast cancer.